Back to team

Bryan Dechairo

,

PhD

Chief Technology and Innovation Officer

Bryan Dechairo serves as the Chief Technology and Innovation Officer at GeneDx. In his role Bryan oversees the company’s AI, Technology, and R&D innovation teams. He is responsible for driving operational excellence as the company enters the next phase of commercial growth.

Bryan brings over 30 years of experience in exploratory and commercial diagnostic businesses, driving the development of revenue-generating clinical innovations that enhance patient outcomes. Learn more about Bryan's leadership role at GeneDx.

Insights from

Bryan Dechairo

Technology
Genome
NICU
Genetic Testing
More GeneDx testing options are coming to your EHR

The latest GeneDx EHR release expands prenatal testing options, adds ultraRapid GenomeDx® duo and trio ordering, and brings helpful guidance into existing clinical workflows. Organizations must update their integration to access these capabilities.

Genetic Testing
Exome
Genome
Advanced genetic testing. Made simpler.

Understanding a test report just got easier. Our new Report Guide brings clear, plain-language guidance directly alongside each eligible patient report.

Prenatal
Exome
Genome
Genetic Testing
Prenatal exome-to-genome reflex: One order. A seamless path from exome to genome

Prenatal Exome-to-Genome Reflex gives providers a flexible way to begin with exome sequencing while preserving a seamless path to genome analysis when additional answers are needed—all from one order and one sample.

Exome
Genome
Technology
Exome-to-Genome Reflex Ordering Is Now Available in Epic Aura

GeneDx's August EHR release introduces Exome-to-Genome Reflex ordering in Epic Aura and supported point-to-point EHR integrations, along with prior authorization enhancements that help providers reduce delays, minimize reorders, and keep genetic testing moving.

Exome
Genomics
Technology
GeneDx launches Easy Order for ExomeDx™ with CMA in the provider portal

GeneDx has launched Easy Order, a guided Provider Portal experience designed to help providers submit eligible ExomeDx™ orders with CMA more efficiently, with fewer manual steps and more complete information from the start.

Exome
Developmental Delay
Pediatrics
Epilepsy
Expanding the availability of exome testing for children with developmental delays and epilepsy

GeneDx is expanding accessibility to exome testing for children with developmental delay, intellectual disability, and epilepsy through a new online offering that connects eligible families with licensed healthcare providers for clinician-guided testing.

Genetic Testing
Education
Exome
Genome
Counseling
A clearer path forward: New genetic test reports designed with patients and families in mind

GeneDx has redesigned its exome and genome test reports to make results easier to find, understand, and discuss. See how the new format improves the experience while preserving the same trusted scientific interpretation.

AI
Rare Disease Diagnostics
Technology
Variant
From thousands of variants to one answer

Learn how GeneDx uses AI-powered variant prioritization through MIMI Ranker to help clinical teams analyze exome and genome sequencing results, surface clinically relevant variants, and support faster rare disease diagnosis.

NICU
Pediatrics
Genomics
Genome
Rare Disease Diagnostics
When every minute matters: Introducing GenomeDx™ ultraRapid Duo and Trio

GeneDx has expanded its ultraRapid genome sequencing portfolio with GenomeDx™ ultraRapid duo and trio testing for critically ill infants and children. By incorporating genetic data from one or both parents, these options help clarify genetic findings and support time-sensitive clinical decisions in NICU and PICU settings.